The World Health Organization (WHO)—the self-appointed deep-state operative aiming to exploit society when it decides there is a global health emergency—asserts on its website that it “connects nations, partners, and people to keep the world safe … so everyone everywhere can attain the highest level of health.” Yet, despite its bold proclamations, according to STAT, the WHO has categorically failed to protect children around the world from receiving “substandard” chemotherapy drugs. And that’s not all. The worst part is that the WHO, along with national drug regulators around the globe, have known that children are receiving the fatal drugs for a year and have failed to take meaningful action. Why?
In January 2023, as reported by STAT, the Bureau of Investigative Journalism (TBIJ) revealed that at least a dozen brands of the childhood chemotherapy drug asparaginase had “failed quality tests.” Nevertheless, despite being on the WHO’s 2023 list of Essential Medicines, the non-government organization (NGO) that counts its most significant donors as the United States, Germany, and Bill Gates has issued no warning alert about the potentially dangerous cancer drug. Frustrated that these tainted brands are still for sale, Gregory Reaman, a scientific director at the National Cancer Institute, spoke of the horrible situation, sharing with STAT:
“This issue is something that needs to be addressed urgently. These are children who are already sick, and have the potential for being cured. And yet they are given substandard drugs.”
Why hasn’t the WHO issued a medical product alert to governments to prompt them to take action to protect children from these dangerous brands of a vital chemotherapy drug? According to TBIJ, experts estimate at least 70,000 children around the world are at risk, with the “substandard” brands—which have been found to contain contaminants such as harmful bacteria—being shipped to more than 90 countries in the past five years. Surely “substandard” asparaginase isn’t the same ruse as the camouflaged mRNA COVID-19 jab, so why is the WHO ignoring the health of these children? What’s going on? As noted by TBIJ, one of the quickest ways to do its job as the almighty protector of the health of the world’s people is to warn governments about dangerous and ineffective drugs. Such a warning would encourage governments to recall the drugs and investigate the manufacturers.
According to the WHO, it first received information regarding potentially “substandard” asparaginase in February 2022 from veteran child cancer specialist Ronald Barr, professor emeritus in pediatrics at McMaster University in Canada. Besides Barr, who notified the WHO that “there was an obvious problem,” TBIJ reported that researchers in India and Brazil have published studies indicating that several brands of asparaginase were “substandard.” And the European Parliament has begun an inquiry, but thus far, has turned up no hard evidence. Nevertheless, Barr shared he fully expected the WHO to investigate the concerns over “substandard” asparaginase immediately and issue the same kind of alert warning the world about fatally contaminated cough syrup in 2022 and 2023. That unfortunate situation impacted roughly 300 children, not 70,000.
Acute lymphoblastic leukemia (ALL) is the most common kind of childhood cancer. TBIJ notes that the treatment is often brutal, consisting of a cocktail of chemotherapy drugs that leave children skeletal, lethargic, and vomiting. According to one cancer doctor, the treatment process is a fine art: “to almost kill a child, but not quite.” And one of the most significant chemotherapy drugs in the cocktail is asparaginase. Without it, patients “face a dramatically reduced chance of survival.” Perhaps that explains why it is listed on the WHO’s list of Essential Medicines.
Asparaginase, which stops cancer cells from dividing and growing, is an enzyme, a protein living organisms produce to speed up chemical reactions in the body. In this case, asparaginase breaks down an amino acid called asparagine, which cells need to survive. White blood cells can typically make their own asparagine, but cancerous white blood cells cannot. So, when asparaginase breaks down asparagine, there is less of it in the body for cancer cells to use; thus, they stop dividing and growing.
Like most chemotherapy drugs, asparaginase is not without severe side effects, including an increased risk of infection, blood clots, inflammation of the pancreas, and allergic reactions, including anaphylaxis. So obviously, a substandard product could quickly lead to disastrous results. As such, it makes sense that substandard products should be removed immediately. Asparaginase is administered over several months at the commencement of treatment either into a vein or as an injection into a muscle. With that in mind, according to TBIF, doctors prefer to use modified versions of asparaginase, which stay in the body for longer.
STAT’s report highlighted “substandard” asparaginase in multiple countries, with many national governments reluctant to take responsibility for the contaminated asparaginase in their countries. It appears they’re all waiting on the WHO to take action. Yet, for its part, the WHO claims it has not received any “actionable information” from the governments of the countries that appear in TBIJ’s reporting, many of which are low- and middle-income countries. STAT notes that “while TBIJ’s investigation has made an impact,” effective action by national regulatory agencies to protect children from tainted asparaginase “remains elusive.” Meanwhile, the WHO insists there are no proven “significant issues of concern.” So, what’s really going on here? STAT quoted a seemingly frustrated Barr, who remarked:
“The response from WHO defies belief. Dismissal of evidence published in highly reputable journals following peer review indicates a combination of incompetence and refuge in bureaucracy, which should require investigation of the [WHO substandard medicines] team by a higher authority within the organization.”
This unfortunate—and, to be honest, quite murky—situation involves children, drugs, sickness, death, and low- to middle-income countries. Then, add in the deep-state-funded WHO and puppet governments, and we have a recipe for duplicity. Knowing that, something is still missing. The connection Gates has to the WHO is well known. Conveniently, it turns out the Bill and Melinda Gates Foundation also funds TBIJ. Of course, TBIJ makes a point of noting that “none of our funders have any influence over the Bureau’s editorial decisions or output.” Hmmm. Right. But besides that, there is now a solution to the “substandard” asparaginase problem. Thanks to the “special report” written by Barr and two TBIJ investigators following the asparaginase/WHO debacle (titled “The international scandal of defective asparaginase: A blight on children with cancer”), a new testing device is coming out to “catch defective cancer drugs.” And it will include asparaginase.
The device, known as chemoPADs, is designed to detect ineffective or contaminated forms of cancer drugs. Professor Marya Lieberman of the University of Notre Dame is developing it. In a report introducing the new device, Gates-funded TBIJ explained that it alerted Lieberman to its findings around “substandard” asparaginase. TBIJ also shared with her the special report by Barr and its two investigators. Now, Lieberman has made asparaginase a focus of her work as she develops devices that flag “poor-quality” medicines.
Interestingly, in 2014, Lieberman’s PADs Project (Paper Analytical Device Project) was awarded initiative funding by the Bill and Melinda Gates Foundation. And today, PADs Global Partners list includes MSH (funded by Gates), AMPATH (funded by Gates), and the Kenyan Pharmacy and Poisons Board (funded by Gates). Likewise, PADs lists its funding as coming from the Global Alliance for Improved Nutrition (funded by Gates), USAID (funded by Gates), the National Institutes of Health, and, of course, the Bill and Melinda Gates Foundation.
Sigh. The Gates connection explains the stagnant and shady “substandard” asparaginase situation and the WHO’s complacency around a serious problem involving innocent children. And it opens the door to the need for a much deeper investigation.